In November 2013, legislators initially introduced the Drug Quality and Security Act (DQSA) - a proposed law that would include the Compounding Quality Act and the Drug Supply Chain Security Act. The first sets up a voluntary compliance arrangement for pharmaceutical firms and the other requires the FDA to develop a national track-and-trace system that manufacturers must use when introducing products into the supply chain.